Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Primary CD30-Positive T-Cell Lymphoproliferative Disorder — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm
Lymphocytic Neoplasm
T-Cell and NK-Cell Neoplasm
Mature T-Cell and NK-Cell Neoplasm
Primary CD30-Positive T-Cell Lymphoproliferative Disorder

Molecular Subtype

Primary CD30-Positive T-Cell Lymphoproliferative Disorder

CI-CAN-00006485Explore in graph →

HematologicNon-malignant5 active trials

NCIt: C202952

Overview
Statistics
Survival
Genomics
Variants & evidence
Drugs
Trials13
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

13 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 4 Recruiting 4 Active Not Recruiting 3 Not Yet Recruiting 1 Withdrawn 1

PhaseAll N/A 3 Phase 1 2 Phase 2 4 Phase 3 1

No study matches these filters